Rimm DL - Search Results

1

Immunological Differences Between Immune-Rich Estrogen Receptor-Positive and Immune-Rich Triple-Negative Breast Cancers.

O'Meara T, Marczyk M, Qing T, Yaghoobi V, Blenman K, Cole K, Pelekanou V, Rimm DL, Pusztai L. O'Meara T, et al. Among authors: rimm dl. JCO Precis Oncol. 2020 Jun 26;4:PO.19.00350. doi: 10.1200/PO.19.00350. eCollection 2020. JCO Precis Oncol. 2020. PMID: 32923897 Free PMC article.

2

In situ tumor PD-L1 mRNA expression is associated with increased TILs and better outcome in breast carcinomas.

Schalper KA, Velcheti V, Carvajal D, Wimberly H, Brown J, Pusztai L, Rimm DL. Schalper KA, et al. Among authors: rimm dl. Clin Cancer Res. 2014 May 15;20(10):2773-82. doi: 10.1158/1078-0432.CCR-13-2702. Epub 2014 Mar 19. Clin Cancer Res. 2014. PMID: 24647569

3

Unvalidated antibodies and misleading results.

Rimm D, Schalper K, Pusztai L. Rimm D, et al. Breast Cancer Res Treat. 2014 Sep;147(2):457-8. doi: 10.1007/s10549-014-3061-0. Epub 2014 Aug 3. Breast Cancer Res Treat. 2014. PMID: 25086631 Free PMC article. No abstract available.

4

PD-L1 Expression Correlates with Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy in Breast Cancer.

Wimberly H, Brown JR, Schalper K, Haack H, Silver MR, Nixon C, Bossuyt V, Pusztai L, Lannin DR, Rimm DL. Wimberly H, et al. Among authors: rimm dl. Cancer Immunol Res. 2015 Apr;3(4):326-32. doi: 10.1158/2326-6066.CIR-14-0133. Epub 2014 Dec 19. Cancer Immunol Res. 2015. PMID: 25527356 Free PMC article.

5

Measurement of Domain-Specific HER2 (ERBB2) Expression May Classify Benefit From Trastuzumab in Breast Cancer.

Carvajal-Hausdorf DE, Schalper KA, Pusztai L, Psyrri A, Kalogeras KT, Kotoula V, Fountzilas G, Rimm DL. Carvajal-Hausdorf DE, et al. Among authors: rimm dl. J Natl Cancer Inst. 2015 May 19;107(8):djv136. doi: 10.1093/jnci/djv136. Print 2015 Aug. J Natl Cancer Inst. 2015. PMID: 25991002 Free PMC article.

6

Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non-Small-Cell Lung Cancer.

McLaughlin J, Han G, Schalper KA, Carvajal-Hausdorf D, Pelekanou V, Rehman J, Velcheti V, Herbst R, LoRusso P, Rimm DL. McLaughlin J, et al. Among authors: rimm dl. JAMA Oncol. 2016 Jan;2(1):46-54. doi: 10.1001/jamaoncol.2015.3638. JAMA Oncol. 2016. PMID: 26562159 Free PMC article.

7

miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer.

Adams BD, Wali VB, Cheng CJ, Inukai S, Booth CJ, Agarwal S, Rimm DL, Győrffy B, Santarpia L, Pusztai L, Saltzman WM, Slack FJ. Adams BD, et al. Among authors: rimm dl. Cancer Res. 2016 Feb 15;76(4):927-39. doi: 10.1158/0008-5472.CAN-15-2321. Epub 2015 Dec 16. Cancer Res. 2016. PMID: 26676753 Free PMC article.

8

Quantitative assessment of the spatial heterogeneity of tumor-infiltrating lymphocytes in breast cancer.

Mani NL, Schalper KA, Hatzis C, Saglam O, Tavassoli F, Butler M, Chagpar AB, Pusztai L, Rimm DL. Mani NL, et al. Among authors: rimm dl. Breast Cancer Res. 2016 Jul 29;18(1):78. doi: 10.1186/s13058-016-0737-x. Breast Cancer Res. 2016. PMID: 27473061 Free PMC article.

9

Quantitative and pathologist-read comparison of the heterogeneity of programmed death-ligand 1 (PD-L1) expression in non-small cell lung cancer.

Rehman JA, Han G, Carvajal-Hausdorf DE, Wasserman BE, Pelekanou V, Mani NL, McLaughlin J, Schalper KA, Rimm DL. Rehman JA, et al. Among authors: rimm dl. Mod Pathol. 2017 Mar;30(3):340-349. doi: 10.1038/modpathol.2016.186. Epub 2016 Nov 11. Mod Pathol. 2017. PMID: 27834350 Free PMC article.

10

Non-malignant respiratory epithelial cells preferentially proliferate from resected non-small cell lung cancer specimens cultured under conditionally reprogrammed conditions.

Gao B, Huang C, Kernstine K, Pelekanou V, Kluger Y, Jiang T, Peters-Hall JR, Coquelin M, Girard L, Zhang W, Huffman K, Oliver D, Kinose F, Haura E, Teer JK, Rix U, Le AT, Aisner DL, Varella-Garcia M, Doebele RC, Covington KR, Hampton OA, Doddapaneni HV, Jayaseelan JC, Hu J, Wheeler DA, Shay JW, Rimm DL, Gazdar A, Minna JD. Gao B, et al. Among authors: rimm dl. Oncotarget. 2017 Feb 14;8(7):11114-11126. doi: 10.18632/oncotarget.14366. Oncotarget. 2017. PMID: 28052041 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

514 results

Search Page

Filters